{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:08:51Z","timestamp":1792667331080,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":76,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.fertnstert.2012.12.048","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T16:40:17Z","timestamp":1360082417000},"page":"1644-1653.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"title":["Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients"],"prefix":"10.1016","volume":"99","clinical-trial-number":[{"clinical-trial-number":"nct00884221","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Joan-Carles","family":"Arce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"La Marca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarke","family":"Mirner Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Nyboe Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2012.12.048_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/GCO.0b013e3283384911","article-title":"The role of anti-m\u00fcllerian hormone assessment in assisted reproductive technology outcome","volume":"22","author":"Broer","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-m\u00fcllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib3","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/humrep\/des101","article-title":"The value of anti-m\u00fcllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response, dose adjustments, embryo quality and pregnancy","volume":"27","author":"Anckaert","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib4","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.fertnstert.2004.03.061","article-title":"Serum antim\u00fcllerian hormone\/m\u00fcllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol","volume":"82","author":"Hazout","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib5","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1471-0528.2004.00452.x","article-title":"Inhibin B and anti-m\u00fcllerian hormone: markers of ovarian response in IVF\/ICSI patients?","volume":"111","author":"Muttukrishna","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib6","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","article-title":"Circulating basal anti-m\u00fcllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in\u00a0vitro fertilization","volume":"92","author":"Nardo","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/humrep\/deh718","article-title":"Basal and stimulation day 5 anti-m\u00fcllerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment","volume":"20","author":"Pe\u00f1arrubia","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum m\u00fcllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/dem254","article-title":"Serum anti-m\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles","volume":"23","author":"Lee","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib12","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-m\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.fertnstert.2006.06.019","article-title":"Antim\u00fcllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in\u00a0vitro fertilization or intracytoplasmic sperm injection","volume":"87","author":"Smeenk","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib14","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1093\/humrep\/deq204","article-title":"Anti-m\u00fcllerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction","volume":"25","author":"Lee","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib15","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/humrep\/der318","article-title":"Predictive factors of ovarian response and clinical outcome after IVF\/ICSI following a rFSH\/GnRH antagonist protocol with or without oral contraceptive pre-treatment","volume":"26","author":"Nyboe Andersen","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib16","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.rbmo.2012.01.024","article-title":"Anti-m\u00fcllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors","volume":"24","author":"Polyzos","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.fertnstert.2011.12.016","article-title":"A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer","volume":"97","author":"Devroey","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib18","series-title":"Towards reproductive certainty: fertility and genetics beyond 1999","first-page":"378","article-title":"In-vitro culture of human blastocysts","author":"Gardner","year":"1999"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing areas under two or more correlated receiver operating characteristics curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter- and intra-cycle variability of anti-m\u00fcllerian hormone and antral follicle counts","volume":"25","author":"van Disseldorp","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.fertnstert.2012.02.012","article-title":"Assessment of FSHR variants and antim\u00fcllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation","volume":"97","author":"Binder","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/humrep\/deh663","article-title":"Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial","volume":"20","author":"Klinkert","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10815-008-9266-6","article-title":"Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve","volume":"25","author":"Lekamge","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-m\u00fcllerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib26","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/humrep\/der182","article-title":"Anti-m\u00fcllerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF","volume":"26","author":"Yates","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.fertnstert.2005.09.019","article-title":"Early follicular antim\u00fcllerian hormone as an indicator of ovarian reserve","volume":"85","author":"Fi\u00e7icioglu","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib28","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-m\u00fcllerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.12.048_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rbmo.2009.10.009","article-title":"Anti-m\u00fcllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors","volume":"20","author":"Nakhuda","year":"2010","journal-title":"Reprod Biomed Online"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:05:57Z","timestamp":1758009957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028213000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0015028213000101"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2012.12.048","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717985413.793472589","asserted-by":"object"}]},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2012.12.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Reproductive Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}